Appili Book Value Per Share from 2010 to 2026

APLI Stock  CAD 0.02  0.01  20.00%   
Appili Therapeutics Book Value Per Share yearly trend continues to be very stable with very little volatility. Book Value Per Share is likely to grow to -0.12 this year. Book Value Per Share is the ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of Appili Therapeutics according to its financial statements. View All Fundamentals
 
Book Value Per Share  
First Reported
2010-12-31
Previous Quarter
(0.13)
Current Value
(0.12)
Quarterly Volatility
0.11514606
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Appili Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Appili Therapeutics' main balance sheet or income statement drivers, such as Interest Income of 4.6 M, Depreciation And Amortization of 11.3 K or Interest Expense of 4.2 M, as well as many indicators such as Price To Sales Ratio of 40.48, Dividend Yield of 0.0 or Days Sales Outstanding of 5.7 K. Appili financial statements analysis is a perfect complement when working with Appili Therapeutics Valuation or Volatility modules.
  
This module can also supplement various Appili Therapeutics Technical models . Check out the analysis of Appili Therapeutics Correlation against competitors.
Evaluating Appili Therapeutics's Book Value Per Share across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Appili Therapeutics's fundamental strength.

Latest Appili Therapeutics' Book Value Per Share Growth Pattern

Below is the plot of the Book Value Per Share of Appili Therapeutics over the last few years. It is the ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements. Appili Therapeutics' Book Value Per Share historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Appili Therapeutics' overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported (0.12) X10 Years Trend
Slightly volatile
   Book Value Per Share   
       Timeline  

Appili Book Value Per Share Regression Statistics

Arithmetic Mean0.03
Geometric Mean0.08
Coefficient Of Variation378.32
Mean Deviation0.09
Median0.05
Standard Deviation0.12
Sample Variance0.01
Range0.3877
R-Value(0.48)
Mean Square Error0.01
R-Squared0.23
Significance0.05
Slope(0.01)
Total Sum of Squares0.21

Appili Book Value Per Share History

2026 -0.12
2025 -0.13
2024 -0.11
2023 -0.0901
2022 -0.065
2021 -0.049
2020 0.22

About Appili Therapeutics Financial Statements

Appili Therapeutics investors utilize fundamental indicators, such as Book Value Per Share, to predict how Appili Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Book Value Per Share(0.13)(0.12)
Tangible Book Value Per Share(0.13)(0.12)

Pair Trading with Appili Therapeutics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Appili Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Appili Therapeutics will appreciate offsetting losses from the drop in the long position's value.

Moving against Appili Stock

  0.42ETG Entree ResourcesPairCorr
  0.39NICU Magna MiningPairCorr
  0.35AIM Aimia IncPairCorr
  0.35CU-PH Canadian UtilitiesPairCorr
  0.33RKR ROKMASTER Resources CorpPairCorr
The ability to find closely correlated positions to Appili Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Appili Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Appili Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Appili Therapeutics to buy it.
The correlation of Appili Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Appili Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Appili Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Appili Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Other Information on Investing in Appili Stock

Appili Therapeutics financial ratios help investors to determine whether Appili Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Appili with respect to the benefits of owning Appili Therapeutics security.